BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12648459)

  • 1. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation.
    York IA; Mo AX; Lemerise K; Zeng W; Shen Y; Abraham CR; Saric T; Goldberg AL; Rock KL
    Immunity; 2003 Mar; 18(3):429-40. PubMed ID: 12648459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
    Rock KL; York IA; Goldberg AL
    Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis and class I major histocompatibility complex antigen presentation.
    York IA; Goldberg AL; Mo XY; Rock KL
    Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating MHC class I ligands from viral gene products.
    Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
    Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases.
    Saveanu L; Fruci D; van Endert P
    Mol Immunol; 2002 Oct; 39(3-4):203-15. PubMed ID: 12200051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.
    Reits E; Griekspoor A; Neijssen J; Groothuis T; Jalink K; van Veelen P; Janssen H; Calafat J; Drijfhout JW; Neefjes J
    Immunity; 2003 Jan; 18(1):97-108. PubMed ID: 12530979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase.
    Saric T; Beninga J; Graef CI; Akopian TN; Rock KL; Goldberg AL
    J Biol Chem; 2001 Sep; 276(39):36474-81. PubMed ID: 11479311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation.
    Silva CL; Portaro FC; Bonato VL; de Camargo AC; Ferro ES
    Biochem Biophys Res Commun; 1999 Feb; 255(3):591-5. PubMed ID: 10049755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol.
    Portaro FC; Gomes MD; Cabrera A; Fernandes BL; Silva CL; Ferro ES; Juliano L; de Camargo AC
    Biochem Biophys Res Commun; 1999 Feb; 255(3):596-601. PubMed ID: 10049756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.
    Goldberg AL; Cascio P; Saric T; Rock KL
    Mol Immunol; 2002 Oct; 39(3-4):147-64. PubMed ID: 12200047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway.
    Kunisawa J; Shastri N
    Mol Cell; 2003 Sep; 12(3):565-76. PubMed ID: 14527404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of cell proteins and the generation of MHC class I-presented peptides.
    Rock KL; Goldberg AL
    Annu Rev Immunol; 1999; 17():739-79. PubMed ID: 10358773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of proteasomes in antigen presentation.
    Gaczynska M; Rock KL; Goldberg AL
    Enzyme Protein; 1993; 47(4-6):354-69. PubMed ID: 7697133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases.
    Saric T; Graef CI; Goldberg AL
    J Biol Chem; 2004 Nov; 279(45):46723-32. PubMed ID: 15328361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.
    Serna A; Ramirez MC; Soukhanova A; Sigal LJ
    J Immunol; 2003 Dec; 171(11):5668-72. PubMed ID: 14634072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomes get by with lots of help from their friends.
    Yewdell JW; Princiotta MF
    Immunity; 2004 Apr; 20(4):362-3. PubMed ID: 15084265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endoplasmic reticulum-associated protein degradation in MHC class I antigen processing.
    Wang Y; Chen D; Androlewicz MJ
    Immunol Rev; 1999 Dec; 172():67-72. PubMed ID: 10631937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly and intracellular transport of MHC class I and class II molecules.
    Jackson MR; Früh K; Karlsson L; Teyton L; Yang Y; Peterson PA
    Cold Spring Harb Symp Quant Biol; 1995; 60():249-61. PubMed ID: 8824398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.